The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research
Eric Groce
- Vol. 104, Iss: 4, pp 32-32
Reads0
Chats0
TLDR
Despite increased cannabis use and a changing state-level policy landscape, conclusive evidence regarding the shortand long-term health effects—both harms and benefits—of cannabis use remains elusive.Abstract:
Recent years have seen a rapid rise in the medical and recreational use of cannabis: a broad term that can be used to describe the various products and chemical compounds (e.g., marijuana, cannabinoids) derived from different species of the cannabis plant. Despite increased cannabis use and a changing state-level policy landscape, conclusive evidence regarding the shortand long-term health effects—both harms and benefits—of cannabis use remains elusive.read more
Citations
More filters
Journal ArticleDOI
Cannabis, Cannabinoids and Cannabis-Based Medicines in Cancer Care
TL;DR: Oncologists should familiarize themselves with the available database to be able to better advise their patients on the potential uses of this complementary botanical therapy, and to evaluate whether the preclinical antitumor effects translate into benefit for cancer patients.
Journal ArticleDOI
A content analysis of internet information sources on medical cannabis.
TL;DR: Given the rise in cannabis use within the U.S. and the reliance on the Internet as a source of information, considerable efforts are needed to provide accurate on-line cannabis education to minimize harms and maximize benefits for individuals and society.
Journal ArticleDOI
The Effects of Medical Marijuana Laws on Utilization of Prescribed Opioids and Other Prescription Drugs
TL;DR: It is found that MMLs lead to a $2.47 decrease in per person prescribed opioid spending among young adults (ages 18-39) over a year, which results from the intensive margin of use and MML states that allow home cultivation experience even larger decreases.
Journal ArticleDOI
Refinement of cg05575921 demethylation response in nascent smoking
Kelsey Dawes,Allan M. Andersen,Emma Papworth,Brandon Hundley,Natasha Hutchens,Heba El Manawy,Ashley Becker,Luke Sampson,Willem Philibert,Frederick X. Gibbons,Meg Gerrard,Robert A. Philibert +11 more
TL;DR: It is concluded that cg05575921 methylation is a sensitive, dose-dependent indicator of early stages of smoking, and may help to identify smokers in the early stage of smoking.
Posted ContentDOI
Facilitators and barriers to the regulation of medical cannabis: a scoping review of the peer-reviewed literature
TL;DR: A scoping review was conducted to identify the facilitators and barriers associated with the implementation of international MC regulations and provide a holistic overview of what factors are proposed to affect MC regulation.
References
More filters
Journal ArticleDOI
Diagnostic and Statistical Manual of Mental Disorders
Vijay A. Mittal,Elaine F. Walker +1 more
TL;DR: An issue concerning the criteria for tic disorders is highlighted, and how this might affect classification of dyskinesias in psychotic spectrum disorders.
Journal ArticleDOI
Systematic Review: Process of Forming Academic Service Partnerships to Reform Clinical Education
TL;DR: This study’s findings can provide practical guidelines to steer partnership programs within the academic and clinical bodies, with the aim of providing a collaborative partnership approach to clinical education.
Journal ArticleDOI
The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials
Julian P T Higgins,Douglas G. Altman,Peter C Gøtzsche,Peter Jüni,David Moher,Andrew D Oxman,Jelena Savović,Kenneth F. Schulz,Laura Weeks,Jonathan A C Sterne +9 more
TL;DR: The Cochrane Collaboration’s tool for assessing risk of bias aims to make the process clearer and more accurate.
The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses
TL;DR: The Newcastle-Ottawa Scale (NOS) as discussed by the authors was developed to assess the quality of nonrandomised studies with its design, content and ease of use directed to the task of incorporating the quality assessments in the interpretation of meta-analytic results.
Journal ArticleDOI
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review
Theresa Hm Moore,Stanley Zammit,Stanley Zammit,Anne Lingford-Hughes,Thomas R. E. Barnes,Peter B. Jones,Margaret Burke,Glyn Lewis +7 more
TL;DR: There is now sufficient evidence to warn young people that using cannabis could increase their risk of developing a psychotic illness later in life, although evidence for affective outcomes is less strong.